Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 12885
TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737441(US20250136608, Compound 6-2)
Affinity DataIC50: 1.10nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM50391992(INCB018424 SALT | Jakafi | RUXOLITINIB PHOSPHATE |...)
Affinity DataIC50: 1.30nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737437(US20250136608, Compound 3)
Affinity DataIC50: 1.90nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737436(US20250136608, Compound 2-2)
Affinity DataIC50: 2.70nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737434(US20250136608, Compound 1)
Affinity DataIC50: 2.80nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737435(US20250136608, Compound 2-1)
Affinity DataIC50: 3.30nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737442(US20250136608, Compound 7)
Affinity DataIC50: 4.30nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737439(US20250136608, Compound 5)
Affinity DataIC50: 5.60nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737440(US20250136608, Compound 6-1)
Affinity DataIC50: 8nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737438(US20250136608, Compound 4)
Affinity DataIC50: 11.1nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737444(US20250136608, Compound 9)
Affinity DataIC50: 13.3nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737443(US20250136608, Compound 8)
Affinity DataIC50: 15nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM50391992(INCB018424 SALT | Jakafi | RUXOLITINIB PHOSPHATE |...)
Affinity DataIC50: 37.8nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737436(US20250136608, Compound 2-2)
Affinity DataIC50: 61.4nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737441(US20250136608, Compound 6-2)
Affinity DataIC50: 116nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737435(US20250136608, Compound 2-1)
Affinity DataIC50: 122nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737437(US20250136608, Compound 3)
Affinity DataIC50: 151nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737434(US20250136608, Compound 1)
Affinity DataIC50: 241nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737440(US20250136608, Compound 6-1)
Affinity DataIC50: 311nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737444(US20250136608, Compound 9)
Affinity DataIC50: 401nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737438(US20250136608, Compound 4)
Affinity DataIC50: 402nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737443(US20250136608, Compound 8)
Affinity DataIC50: 419nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737442(US20250136608, Compound 7)
Affinity DataIC50: 479nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Cgenetech (Suzhou, China) Co.

US Patent
LigandPNGBDBM737439(US20250136608, Compound 5)
Affinity DataIC50: 488nMAssay Description:1) Treatment wells of the compound to be tested (T-compound): In HTRF 96 well low volume plate, 4 μL of 2.5×the compound to be tested described above...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
US Patent